Company profile
Surgitate company profile
Surgitate fabricates synthetic models that surgeons, medical and veterinary students, and other medical staff such as nurses and obstetricians can practice on. Their models are designed to create a realistic feel of incision, dissection, and suturing. Their cofounders are a materials engineer (Ozge Akbulut, PhD) and a thoracic surgeon (Barkın Eldem, MD). Surgitate has two investors: Farplas, leading plastic automotive parts manufacturer in Turkey, and Inovent, Turkey’s first technology commercialization/accelerator and seed funding company. They rely on expertise of Farplas in process development, molding, and painting for the mass scale production of synthetic body parts. Inovent assures that we are well-connected to our potential investors and customers; and handles business and marketing plans.
Business identity
- Website
- http://www.surgitate.com/
- Contact email
- [email protected]
- Phone number
- +90 5332472920
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0+
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Balatcık, Aydın, Turkey
- Country code
- TR
- Continent
- Asia